ATE69551T1 - Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren. - Google Patents
Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.Info
- Publication number
- ATE69551T1 ATE69551T1 AT84201131T AT84201131T ATE69551T1 AT E69551 T1 ATE69551 T1 AT E69551T1 AT 84201131 T AT84201131 T AT 84201131T AT 84201131 T AT84201131 T AT 84201131T AT E69551 T1 ATE69551 T1 AT E69551T1
- Authority
- AT
- Austria
- Prior art keywords
- animals
- treatment
- composition
- malignant tumors
- administration
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000003211 malignant effect Effects 0.000 title 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract 1
- 229930024421 Adenine Natural products 0.000 abstract 1
- 108010026373 Cystine reductase Proteins 0.000 abstract 1
- 101100080807 Drosophila melanogaster mt:ND2 gene Proteins 0.000 abstract 1
- 101150016680 MT-ND2 gene Proteins 0.000 abstract 1
- 102100028488 NADH-ubiquinone oxidoreductase chain 2 Human genes 0.000 abstract 1
- 101150102231 ND2 gene Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000005515 coenzyme Substances 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract 1
- 230000000750 progressive effect Effects 0.000 abstract 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 abstract 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 abstract 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 abstract 1
- 229960001327 pyridoxal phosphate Drugs 0.000 abstract 1
- 230000002269 spontaneous effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT67899/83A IT1162938B (it) | 1983-08-26 | 1983-08-26 | Composizione per la cura dei tumori maligni in particolare sugli animali |
| EP19840201131 EP0135955B1 (de) | 1983-08-26 | 1984-08-02 | Zusammensetzung zur Behandlung von bösartigen Tumoren insbesondere bei Tieren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE69551T1 true ATE69551T1 (de) | 1991-12-15 |
Family
ID=11306198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84201131T ATE69551T1 (de) | 1983-08-26 | 1984-08-02 | Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0135955B1 (de) |
| AT (1) | ATE69551T1 (de) |
| DE (1) | DE3485282D1 (de) |
| IT (1) | IT1162938B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4102240C1 (de) * | 1991-01-24 | 1992-04-09 | Birkmayer, Joerg, Univ.-Prof. Ddr., Wien, At | |
| DE4128625A1 (de) * | 1991-08-26 | 1993-04-08 | Joerg Birkmayer | Medikament gegen krebs und aids |
| US5264220A (en) * | 1991-11-12 | 1993-11-23 | Long David M Jr | Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880918A (en) * | 1982-07-13 | 1989-11-14 | Eliezer Rapaport | Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate |
-
1983
- 1983-08-26 IT IT67899/83A patent/IT1162938B/it active
-
1984
- 1984-08-02 AT AT84201131T patent/ATE69551T1/de not_active IP Right Cessation
- 1984-08-02 DE DE8484201131T patent/DE3485282D1/de not_active Expired - Fee Related
- 1984-08-02 EP EP19840201131 patent/EP0135955B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IT1162938B (it) | 1987-04-01 |
| IT8367899A0 (it) | 1983-08-26 |
| EP0135955A2 (de) | 1985-04-03 |
| EP0135955A3 (en) | 1988-08-17 |
| EP0135955B1 (de) | 1991-11-21 |
| DE3485282D1 (de) | 1992-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8606289A1 (es) | Un procedimiento para la preparacion de piridazinaminas. | |
| NO166943C (no) | Analogifremgangsmaate for fremstilling av enzymresistente immunomodulerende peptider. | |
| AU1808488A (en) | Compounds for the treatment of alzheimer's disease | |
| NO931635D0 (no) | Fremgangsmaate for fremstilling av kinazolin-derivater | |
| DK155143C (da) | Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet | |
| SE8000435L (sv) | N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning | |
| EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
| AU8103782A (en) | Aroylimidazolones | |
| GR1002802B (el) | Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος | |
| JPS57122085A (en) | Circulatory disease extirpenter and use | |
| EP0325129A3 (en) | Disubstituted pyridines | |
| ATE64300T1 (de) | Wirkstoffe zur anwendung bei der behandlung von tumoren. | |
| ATE69551T1 (de) | Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren. | |
| PT83733A (en) | Process for the preparation of cardiotonic thiazolones | |
| ES8704962A1 (es) | Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida. | |
| ES8201578A1 (es) | Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles | |
| ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
| DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
| EP0248217A3 (en) | Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor | |
| AU7025087A (en) | Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base | |
| AU562828B2 (en) | Morphine-vitamin b12 analgesic treatment | |
| ES8801624A1 (es) | Procedimiento para preparar disulfuros heterociclicos | |
| ZA893310B (en) | Novel strobilurine derivatives,their preparation and their use | |
| ES2019713A6 (es) | Un procedimiento para preparar derivados clorados de adenosina. | |
| JPS5227788A (en) | New triazine derivatives and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |